Adagio medical expands chief business officer deborah kaster's role to include chief financial officer responsibilities

Laguna hills, calif.--(business wire)--adagio medical holdings, inc. (nasdaq: adgm) (“adagio” or “the company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that the company's chief business officer, deborah kaster's, responsibilities have been expanded to include the role of chief financial officer, effective september 5, 2025. ms. kaster succeeds dan george, who served as the company's interim chief financial officer since ap.
ADGM Ratings Summary
ADGM Quant Ranking